ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 232 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,222,713 | -3.0% | 679,459 | +25.5% | 1.31% | -2.0% |
| Q2 2023 | $24,978,472 | +1.0% | 541,480 | -12.2% | 1.34% | +28.0% |
| Q1 2023 | $24,720,848 | -34.7% | 616,480 | -24.6% | 1.04% | -34.3% |
| Q4 2022 | $37,859,532 | +928.0% | 817,171 | +818.8% | 1.59% | +939.2% |
| Q3 2022 | $3,683,000 | -82.3% | 88,940 | -74.5% | 0.15% | -80.7% |
| Q2 2022 | $20,793,000 | -45.5% | 348,519 | -33.6% | 0.79% | -32.1% |
| Q1 2022 | $38,133,000 | -6.5% | 525,100 | +8.2% | 1.16% | +47.5% |
| Q4 2021 | $40,804,000 | – | 485,242 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |